Suppr超能文献

简化磁共振序列在肝细胞癌筛查中的价值:一项系统评价与荟萃分析

Value of Abbreviated Magnetic Resonance Sequence in Hepatocellular Carcinoma Screening: A Systematic Review and Meta-analysis.

作者信息

Wang Cong, Zhu Shao-Cheng, Liang Jing-Hong

机构信息

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, PR China (C.W., S.C.Z.).

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, PR China (C.W., S.C.Z.).

出版信息

Acad Radiol. 2025 Jan 4. doi: 10.1016/j.acra.2024.12.024.

Abstract

RATIONALE AND OBJECTIVES

To systematically review the diagnostic efficacy of abbreviated magnetic resonance imaging sequence (AMRI) screening for hepatocellular carcinoma (HCC).

MATERIALS AND METHODS

Medline (via PubMed), EMbase, The Cochrane Library, Web of Science, CNKI, WanFang Data, and VIP databases were electronically searched to collect studies on the diagnostic efficacy of AMRI screening for HCC from inception to August 10th, 2024. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies using the Quality Assessment Tool for Diagnostic Accuracy Studies (QUADAS-2), then, the meta-analysis with a bivariate mixed-effects regression model was performed by using Stata 14.0 software.

RESULTS

A total of 19 studies involving 3914 participants were included which published from 2013 to 2024. The results of meta-analysis showed that pooled sensitivity and specificity of AMRI for HCC were 0.85 (95% confidence interval (CI) 0.83 to 0.87) and 0.93 (95%CI 0.91 to 0.94). Subgroup analysis showed that the pooled sensitivity and specificity of NC (Non-Contrast) AMRI and HBP (Hepatobiliary Phase Images) AMRI were 0.84 (95%CI 0.80 to 0.87), 0.92 (95%CI 0.89 to 0.94) and 0.88 (95%CI 0.84 to 0.91), 0.93 (95%CI 0.91 to 0.95), respectively. And the T2 (T2 Weighted Imaging)+DWI (Diffusion Weighted Imaging)+HBP protocol in HBP AMRI had the highest diagnostic efficacy, its pooled sensitivity, specificity and the area under the summary receiver operating characteristic (SROC) curve (AUC) were 0.88 (95%CI 0.83 to 0.92), 0.93 (95%CI 0.91 to 0.95), and 0.96 (95%CI 0.94 to 0.98), respectively.

CONCLUSION

Current evidence suggests that the AMRI protocols demonstrated potential for HCC detection, which employing a limited number of sequences with the aim of achieving a diagnostic performance comparable to conventional complete contrast-enhanced MRI (CE-MRI). Among them, T2+DWI+HBP protocol shows the relatively highest diagnostic efficiency, which is perhaps the most promising application in clinical practice. Nevertheless, the results still should be carefully interpreted in the relevant context of medical history, physical examination, and biochemical indicators.

摘要

原理与目的

系统评价简化磁共振成像序列(AMRI)筛查肝细胞癌(HCC)的诊断效能。

材料与方法

通过电子检索Medline(经由PubMed)、EMbase、Cochrane图书馆、Web of Science、中国知网、万方数据和维普数据库,收集自起始至2024年8月10日关于AMRI筛查HCC诊断效能的研究。两名研究者独立筛选文献、提取数据,并使用诊断准确性研究质量评估工具(QUADAS-2)评估纳入研究的偏倚风险,然后,使用Stata 14.0软件进行双变量混合效应回归模型的Meta分析。

结果

共纳入2013年至2024年发表的19项研究,涉及3914名参与者。Meta分析结果显示,AMRI对HCC的合并敏感度和特异度分别为0.85(95%置信区间(CI)0.83至0.87)和0.93(95%CI 0.91至0.94)。亚组分析显示,非增强(NC)AMRI和肝胆期图像(HBP)AMRI的合并敏感度和特异度分别为0.84(95%CI 0.80至0.87)、0.92(95%CI 0.89至0.94)和0.88(95%CI 0.84至0.91)、0.93(95%CI 0.91至0.95)。HBP AMRI中的T2加权成像(T2WI)+扩散加权成像(DWI)+HBP方案诊断效能最高,其合并敏感度、特异度和总结接收器操作特征(SROC)曲线下面积(AUC)分别为0.88(95%CI 0.83至0.92)、0.93(95%CI 0.91至0.95)和0.96(95%CI 0.94至0.98)。

结论

当前证据表明,AMRI方案在检测HCC方面显示出潜力,其采用有限数量的序列,旨在实现与传统完整对比增强磁共振成像(CE-MRI)相当的诊断性能。其中,T2+DWI+HBP方案显示出相对最高的诊断效率,可能是临床实践中最有前景的应用。然而,仍应结合病史、体格检查和生化指标等相关背景仔细解读结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验